Elizabeth G. O'Farrell is Director of PDL BIOPHARMA, INC.. Currently has a direct ownership of 0 shares of PDLI, which is worth approximately $0. The most recent transaction as insider was on Nov 23, 2020, when has been sold 25,826 shares (Common Stock) at a price of $2.44 per share, resulting in proceeds of $63,015. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Elizabeth G. O'Farrell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 23 2020
SELL
Open market or private sale
$63,015 $2.44 p/Share
25,826 Reduced 100.0%
0 Common Stock
Nov 18 2020
SELL
Open market or private sale
$150,633 $2.38 p/Share
63,291 Reduced 71.02%
25,826 Common Stock

Also insider at

IKT
Inhibikase Therapeutics, Inc. Healthcare
LNSR
LENSAR, Inc. Healthcare
GERN
GERON CORP Healthcare
EGO

Elizabeth G. O'Farrell

Director
Atlanta, GA

Track Institutional and Insider Activities on PDLI

Follow PDL BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PDLI shares.

Notify only if

Insider Trading

Get notified when an Pdl Biopharma, Inc. insider buys or sells PDLI shares.

Notify only if

News

Receive news related to PDL BIOPHARMA, INC.

Track Activities on PDLI